Cognizant Collaborates with Alnylam as Technology Services Partner to Scale IT Operations
Cognizant (CTSH) has announced a new IT Managed Services partnership with Alnylam Pharmaceuticals, a leading RNAi therapeutics company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Cognizant (CTSH) has announced a new IT Managed Services partnership with Alnylam Pharmaceuticals, a leading RNAi therapeutics company. As the primary IT services provider, Cognizant will manage Alnylam's global infrastructure, operations, cloud, security, platforms, applications, and advanced data analytics. The collaboration aims to enhance automation, reduce operational efforts, and improve business decision transparency using Cognizant's managed services frameworks and tools. This partnership leverages Cognizant's experience working with 30 top global pharmaceutical companies to implement and manage advanced technology solutions.
Positive
- Strategic partnership with a leading biopharmaceutical company expanding Cognizant's life sciences portfolio
- Addition of comprehensive IT services contract covering multiple technology areas
- Strengthens position in pharmaceutical sector where Cognizant already serves 30 top global companies
Negative
- None.
Details
News Market Reaction – CTSH
The recorded move for CTSH in the trading session of this news was +0.72%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Utilizing Cognizant's top-tier managed services frameworks and tools, the partnership aims to enhance Alnylam's automation and reduce operational efforts
Cognizant has been selected as the technology partner responsible for managing Alnylam's global infrastructure and operations, cloud, security, platforms, applications, and advanced data analytics. Leveraging Cognizant's managed services frameworks and tools, the collaboration aims to improve automation, reduce operational efforts, and ensure transparency in business decisions and unified performance accountability.
"By leveraging Cognizant's expertise in the life sciences sector and innovative managed services frameworks, we will aim to accelerate our business outcomes and ultimately improve customer experiences," said Larry Egan, Vice President of Strategic Technologies at Alnylam.
Thirty of the top global pharmaceutical companies work with Cognizant to implement and manage advanced technology solutions, enabling them to bring their innovative drugs to market, run global supply chains and manufacturing systems, and comply with complex regulations.
"We are thrilled to partner with Alnylam on its IT transformation journey," said Cognizant's Mohammad Haque, SVP, Global Large Deals Lead and BU Head, Life Sciences. "We will bring our extensive experience with large pharmaceutical companies, along with investments in AI, to accelerate Alnylam's business goals. As a strategic partner, we look forward to helping Alnylam grow its business and continue delivering transformative medicines to treat both rare and prevalent diseases."
About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we're improving everyday life. See how at www.cognizant.com or @cognizant.
Contact:
Natalie Steffen
Natalie.Steffen@cognizant.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cognizant-collaborates-with-alnylam-as-technology-services-partner-to-scale-it-operations-302290305.html
SOURCE Cognizant Technology Solutions
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.